About Event

The Tumor Models Conference Series is dedicated to exploring the latest advances in the application of preclinical models to enhance the translation of cancer therapies from bench to patient.

  • Be at the interface of model innovation and therapeutic development.
  • Meet a multidisciplinary mix of model developers, translational and pharmacology research scientists.
  • Share knowledge and debatewith the scientific community thanks to a human sized event.
  • Assess how the industry is overcoming challenges in drug development through the use of in vitro & in vivo models.
  • The 3-day agenda, designed with the input of 40+ leading oncology leaders, will strive to answer your burning questions in terms of model validation, translatability and rationale.
  • Benchmark your progress and enhance the translational confidence of your preclinical approaches.
  • Join over 120 attendees from 80 organizations from various backgrounds such as academia, industry and model providing services and define the future of cancer drug development.
About page TMB
HW190322 Tumor models boston graph design